Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Mona Lisa Alattar"'
Publikováno v:
Case Reports in Oncological Medicine, Vol 2015 (2015)
Rhabdomyolysis, a syndrome of muscle necrosis, is a life-threatening event. Here we describe the case of a patient with chronic myeloid leukemia who underwent a haploidentical stem cell transplant and subsequently developed rhabdomyolysis after begin
Externí odkaz:
https://doaj.org/article/3303590393f740f0af9687fc839b7507
Autor:
Zeev Estrov, Lynne V. Abruzzo, Jorge E. Cortes, Pei Lin, Yang O. Huh, Mona Lisa Alattar, Uri Rozovski, Maro Ohanian, Carlos E. Bueso-Ramos, Joseph D. Khoury, Chi Young Ok, Keyur P. Patel
Publikováno v:
Cancer Genetics. 208:571-574
Little is known about MYC dysregulation in myeloid malignancies, and the authors were unable to find published studies that evaluated MYC protein expression in primary cases of myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML). Herein, w
Autor:
Aziz Nazha, Michael Andreeff, Hagop M. Kantarjian, Jorge E. Cortes, Marina Konopleva, Sherry Pierce, Michelle A. Rudek, Naval Daver, Mark J. Levis, Tapan M. Kadia, Jan A. Burger, Sara Dellasala, Michael R. Grunwald, Gautam Borthakur, Trivikram Rajkhowa, Mona Lisa Alattar, Stefan Faderl, Mary Ann Richie, Guillermo Garcia-Manero, Farhad Ravandi
Publikováno v:
Blood. 121:4655-4662
Patients received 5-azacytidine (AZA) 75 mg/m(2) intravenously daily for 7 days and sorafenib 400 mg orally twice daily continuously; cycles were repeated at ~1-month intervals. Forty-three acute myeloid leukemia (AML) patients with a median age of 6
Autor:
Cynthia Ishin Tung, Lynne V. Abruzzo, Zeev Estrov, Maro Ohanian, John T. Manning, Uri Rozovski, Farhad Ravandi, Vikas Kundra, Naveen Pemmaraju, Mona Lisa Alattar
Publikováno v:
British journal of haematology. 180(5)
Publikováno v:
Blood. 132:4918-4918
INTRODUCTION Inherited disorders due to rare structural Hb variants are not included in national, neonatal screening tests and therefore likely underdiagnosed. Hemoglobin New Mexico is one such rare variant with only one case ever reported in 1985 in
Autor:
Srdan Verstovsek, Sara Dellasala, Susan O'Brien, Koji Sasaki, Preetesh Jain, Hagop M. Kantarjian, Jorge E. Cortes, Elias Jabbour, Gautam Borthakur, Sherry Pierce, William G. Wierda, Mona Lisa Alattar, Graciela M. Nogueras González, Farhad Ravandi
Summary Background Several tyrosine kinase inhibitors (TKIs) are available for treatment of patients with chronic myeloid leukaemia in chronic phase (CML-CP). We analysed long-term molecular and cytogenetic response and survival outcomes for four TKI
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a44c57e0b23f0979664fde60a406dcc
https://europepmc.org/articles/PMC4854752/
https://europepmc.org/articles/PMC4854752/
Publikováno v:
Case Reports in Oncological Medicine, Vol 2015 (2015)
Case Reports in Oncological Medicine
Case Reports in Oncological Medicine
Rhabdomyolysis, a syndrome of muscle necrosis, is a life-threatening event. Here we describe the case of a patient with chronic myeloid leukemia who underwent a haploidentical stem cell transplant and subsequently developed rhabdomyolysis after begin
Autor:
Harris V K Naina, Mona Lisa Alattar
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 15:S65-S66
Autor:
Larry D. Anderson, Song Zhang, Harris V K Naina, Prapti A. Patel, Madhuri Vusirikala, Chi Yin Kwong, Mona Lisa Alattar, Robert H. Collins
Publikováno v:
Biology of Blood and Marrow Transplantation. 21:S127-S128
Autor:
Hagop M. Kantarjian, Farhad Ravandi, Jorge E. Cortes, Guillermo Garcia-Manero, Richard E. Champlin, Long Xuan Trinh, Lynne V. Abruzzo, Tapan M. Kadia, Sherry Pierce, Srdan Verstovsek, Maro Ohanian, Elias Jabbour, Susan O'Brien, Alessandra Ferrajoli, Alfonso Quintás-Cardama, Gautam Borthakur, Raja Luthra, Mona Lisa Alattar
Publikováno v:
Clinical lymphoma, myeloma & leukemia, vol 14, iss 2
Background Accelerated phase CML most frequently represents a progression state in CML. However, some patients present with AP features at the time of diagnosis. There is limited information on the outcome of these patients who received TKIs as initi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::228af92cacc419ea1f0d7203dc730208
https://europepmc.org/articles/PMC3959284/
https://europepmc.org/articles/PMC3959284/